A various number of clinical studies have shown that serum MPO and DNA levels are associated with an increased risk of deep vein thrombosis and pulmonary embolism in humans [71,72,73,74] suggesting that MPO levels might be used as a biomarker in patients with PV and ET. The gene discussed is MPO; the disease is pulmonary embolism.